About
Vesalius Longevity Labs is a peptide-focused health company co-founded by Dr. Matt Cook and Jennifer Benson that harnesses peptide science to optimize health and extend healthspan. The company develops a comprehensive portfolio of peptide products available in multiple delivery forms: injectables, patches, nasal sprays, oral peptides, and topical formulations. All products are primarily US-sourced and manufactured in FDA-registered, cGMP-compliant facilities, emphasizing quality, transparency, and trust.
The company operates through a B2Doctor ecosystem that gives independent licensed healthcare providers access to diverse peptide delivery systems and clinical support. Rather than positioning peptides as a consumer trend, Vesalius frames them as a strategic tool for practitioners to offer personalized, performance-oriented care. The company's approach bridges traditional medicine with emerging longevity science, making peptide therapies accessible to providers and patients seeking to strengthen the body's natural processes and optimize wellness beyond baseline health outcomes.
Longevity Contribution
- Exclusively focused on peptides and longevity as the company's sole therapeutic category, with no diversification into other supplement or pharmaceutical areas
- Operates a proprietary B2Doctor ecosystem providing end-to-end support including telehealth, fulfillment, and compliance services for licensed practitioners
- Products manufactured in FDA-registered, cGMP-compliant facilities with emphasis on US-sourced ingredients and quality assurance
- Guided by a team including clinical researchers, MDs, and biotech veterans with expertise in regenerative medicine and longevity science